COVID-19 QUICK DIAGNOSTIC TEST MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-20153 | Others
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Covid-19 Quick Diagnostic Test Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET
7.1 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA COVID-19 QUICK DIAGNOSTIC TEST MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 bioMérieux
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Abbott Diagnostics
16.3 BD
16.4 Cellmid
16.5 Biocartis SA
16.6 Diasorin
16.7 Hardy Diagnostics
16.8 Alveo Technologies
16.9 Cepheid
16.10 Bio-Rad
16.11 Curetis
16.12 Applied BioCode
16.13 Cue Health
16.14 Akonni Biosystems
16.15 Ador Diagnostics (BATM)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Major Types CoveredReverse Transcription PCR
Immunoassay
Genome and Whole Genome Sequencing (WGS)
Major Downstream Industry Covered
hospital
laboratory
Companies
bioMérieux
Abbott Diagnostics
BD
Cellmid
Biocartis SA
Diasorin
Hardy Diagnostics
Alveo Technologies
Cepheid
Bio-Rad
Curetis
Applied BioCode
Cue Health
Akonni Biosystems
Ador Diagnostics (BATM)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.